Blocking immune cells spares brain tissue in mice with Alzheimer’s

In Alzheimer’s disease, tau protein accumulates inside brain cells, leading to cell death and memory loss. The conventional research approach targets tau for removal. But the researchers took a different path: they blocked immune cells that contribute to the destruction of neurons.

Immune cells as co-culprits

In the brain, certain immune cells called microglia are normally protective. In Alzheimer’s disease, however, they can also cause damage. In this mouse experiment, the researchers investigated what happens when that harmful immune response is suppressed. The result was that roughly 40% more tissue in the memory centres was preserved. Memory performance in the mice also improved, even though tau accumulation remained present.

This suggests that the immune response itself is an independent cause of brain damage, alongside tau protein build-up. Whether this mechanism works the same way in humans has not yet been studied. This was an animal experiment and should be interpreted with care.

Why this matters

Many clinical studies targeting tau have failed or shown limited effects. This finding opens the possibility that immune suppression could be a complementary or alternative strategy. It is also conceivable that combining both approaches would be more effective than either alone.

From a longevity perspective, neuroinflammation (chronic inflammation in the brain) is increasingly viewed as a driver of neurodegenerative disease during aging. A treatment that modulates the immune response could potentially be applicable beyond Alzheimer’s. But that remains speculative for now. The first step is to replicate this result in larger and more varied animal models.

Read the original article